Healthcare and life sciences investment professionals believe that deal volume will grow in most sectors in 2020 compared with 2019, but the coming elections could impact the investment outlook, a KPMG LLP survey found. Healthcare IT/revenue cycle management was seen as generating the most investor interest (30%), topping drug makers (pharma/biotech) (24%), but behavioral health and home/hospice care also drew considerable interest (both 23%) of those surveyed. Hospitals and health systems drew interest from only 8 percent of those surveyed, lagging managed care companies at 15 percent. Respondents were given three choices of sectors that generated the most interest. Cost consolidation/economies of scale was selected among the biggest drivers of merger and acquisition activity (58%), followed by accretive acquisition strategies (34%), and changing payment models as leading factor (31%), according to the respondents, who were asked about their top three choices of catalysts for M&A.